[HTML][HTML] Radiolabeled somatostatin analogs—a continuously evolving class of radiopharmaceuticals
M Fani, R Mansi, GP Nicolas, D Wild - Cancers, 2022 - mdpi.com
Simple Summary Somatostatin receptors (SSTs) are of particular interest in oncology
because these proteins are overexpressed on the cell membranes of different human …
because these proteins are overexpressed on the cell membranes of different human …
[HTML][HTML] Peptide receptor radionuclide therapy (PRRT): innovations and improvements
E Merola, CM Grana - Cancers, 2023 - mdpi.com
Simple Summary This article discusses the use of peptide receptor radionuclide therapy
(PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It …
(PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It …
[HTML][HTML] Controversy over liver transplantation or resection for neuroendocrine liver metastasis: tumor biology cuts the deal
D Eshmuminov, DJ Studer, VL Lopez… - Annals of …, 2023 - journals.lww.com
Background: In patients with neuroendocrine liver metastasis (NELM), liver transplantation
(LT) is an alternative to liver resection (LR), although the choice of therapy remains …
(LT) is an alternative to liver resection (LR), although the choice of therapy remains …
[HTML][HTML] New insights in PRRT: lessons from 2021
G Puliani, A Chiefari, M Mormando… - Frontiers in …, 2022 - frontiersin.org
Peptide receptor radionuclide therapy (PRRT) using radiolabeled somatostatin analogs has
been used for over two decades for the treatment of well-differentiated neuroendocrine …
been used for over two decades for the treatment of well-differentiated neuroendocrine …
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
B Kos‐Kudła, JP Castaño, T Denecke… - Journal of …, 2023 - Wiley Online Library
This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …
Effective Treatment of SSTR2-Positive Small Cell Lung Cancer Using 211At-Containing Targeted α-Particle Therapy Agent Which Promotes Endogenous Antitumor …
S Qin, Y Yang, J Zhang, Y Yin, W Liu… - Molecular …, 2023 - ACS Publications
Small cell lung cancer (SCLC) is a neuroendocrine tumor with a high degree of malignancy.
Due to limited treatment options, patients with SCLC have a poor prognosis. We have found …
Due to limited treatment options, patients with SCLC have a poor prognosis. We have found …
[HTML][HTML] Targeted cancer therapy: what's new in the field of neuroendocrine neoplasms?
A La Salvia, P Espinosa-Olarte, MDC Riesco-Martinez… - Cancers, 2021 - mdpi.com
Simple Summary Neuroendocrine neoplasms are highly heterogeneous tumors in terms of
primary origin, molecular landscape, clinical presentation and behavior. To date, several …
primary origin, molecular landscape, clinical presentation and behavior. To date, several …
Clinical pharmacology of radiotheranostics in oncology
ET Te Beek, J Burggraaf… - Clinical …, 2023 - Wiley Online Library
The combined use of diagnostic and therapeutic radioligands with the same molecular
target, also known as theranostics, enables accurate patient selection, targeted therapy, and …
target, also known as theranostics, enables accurate patient selection, targeted therapy, and …
[HTML][HTML] Predictive factors for resistant disease with medical/radiologic/liver-directed anti-tumor treatments in patients with advanced pancreatic neuroendocrine …
L Lee, I Ramos-Alvarez, RT Jensen - Cancers, 2022 - mdpi.com
Simple Summary Tumor resistance, both primary and acquired, is leading to increased
complexity in the nonsurgical treatment of patients with advanced panNENs, which would be …
complexity in the nonsurgical treatment of patients with advanced panNENs, which would be …
[HTML][HTML] Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry …
TSA Abdalla, M Klinkhammer-Schalke… - Journal of Cancer …, 2023 - Springer
Objective The available literature regarding outcome after pancreatic resection in locally
advanced non-functional pNEN (LA-pNEN) is sparse. Therefore, this study evaluates the …
advanced non-functional pNEN (LA-pNEN) is sparse. Therefore, this study evaluates the …